Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyu-Pyo Kim

Showing results (21-30 of 217) with videos related to

Pageof 22
Sort By:
Human Pathology|April 23, 2023
Prognostic significance of extranodal extension of nodal metastasis in adenocarcinoma of the ampulla of VaterJihyun Chun, Yeon Wook Kim, Seo-Rin Jeong, et al.
Cancer Research and Treatment|November 19, 2016
Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing RegimenChanghoon Yoo, Bum Jun Kim, Kyu-Pyo Kim, et al.
Breast Cancer Research and Treatment|September 29, 2017
Phase IB trial of ixabepilone and vorinostat in metastatic breast cancerThehang Luu, Kyu-Pyo Kim, Suzette Blanchard, et al.
Clinical Therapeutics|November 20, 2009
Potential interactions between cilostazol and probucol: a two-part, single-dose, open-label study in healthy Korean male volunteersKyu-pyo Kim, Bo-Hyung Kim, Kyoung Soo Lim, et al.
Basic & Clinical Pharmacology & Toxicology|December 21, 2011
Assessment of the analgesic effect of remifentanil using three pain models in healthy Korean volunteers: a randomized, controlled studyTae-Eun Kim, Kyu-Pyo Kim, Donghoon Shin, et al.
Cancer Chemotherapy and Pharmacology|January 25, 2012
Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapyKyu-pyo Kim, Jin-Hee Ahn, Sung-Bae Kim, et al.
Scientific Reports|March 30, 2021
Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidinesYeong Hak Bang, Jeong Eun Kim, Ji Sung Lee, et al.
Medicina (Kaunas, Lithuania)|November 27, 2025
Embolization with Quick-Soluble Gelatin Sponge Particles for Lower Gastrointestinal Bleeding: A Multicenter StudyChang Ho Jeon, Seung Boo Yang, Woo Jin Yang, et al.
Scientific Reports|November 30, 2021
Real-world data analysis of patients with cancer of unknown primarySora Kang, Jae Ho Jeong, Shinkyo Yoon, et al.
Investigational New Drugs|October 17, 2018
Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scoresInhwan Hwang, Jihoon Kang, Hei Nga Natalie Ip, et al.
Pageof 22

Showing results (21-30 of 217) with videos related to

Sort By:
Pageof 22
Human Pathology|April 23, 2023
Prognostic significance of extranodal extension of nodal metastasis in adenocarcinoma of the ampulla of VaterJihyun Chun, Yeon Wook Kim, Seo-Rin Jeong, et al.
Cancer Research and Treatment|November 19, 2016
Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing RegimenChanghoon Yoo, Bum Jun Kim, Kyu-Pyo Kim, et al.
Breast Cancer Research and Treatment|September 29, 2017
Phase IB trial of ixabepilone and vorinostat in metastatic breast cancerThehang Luu, Kyu-Pyo Kim, Suzette Blanchard, et al.
Clinical Therapeutics|November 20, 2009
Potential interactions between cilostazol and probucol: a two-part, single-dose, open-label study in healthy Korean male volunteersKyu-pyo Kim, Bo-Hyung Kim, Kyoung Soo Lim, et al.
Basic & Clinical Pharmacology & Toxicology|December 21, 2011
Assessment of the analgesic effect of remifentanil using three pain models in healthy Korean volunteers: a randomized, controlled studyTae-Eun Kim, Kyu-Pyo Kim, Donghoon Shin, et al.
Cancer Chemotherapy and Pharmacology|January 25, 2012
Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapyKyu-pyo Kim, Jin-Hee Ahn, Sung-Bae Kim, et al.
Scientific Reports|March 30, 2021
Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidinesYeong Hak Bang, Jeong Eun Kim, Ji Sung Lee, et al.
Medicina (Kaunas, Lithuania)|November 27, 2025
Embolization with Quick-Soluble Gelatin Sponge Particles for Lower Gastrointestinal Bleeding: A Multicenter StudyChang Ho Jeon, Seung Boo Yang, Woo Jin Yang, et al.
Scientific Reports|November 30, 2021
Real-world data analysis of patients with cancer of unknown primarySora Kang, Jae Ho Jeong, Shinkyo Yoon, et al.
Investigational New Drugs|October 17, 2018
Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scoresInhwan Hwang, Jihoon Kang, Hei Nga Natalie Ip, et al.
Pageof 22